The verdict is in: former featherweight title challenger and top contender Chad “Money” Mendes has been handed a two year suspension by the US Anti-Doping Agency after failing an out of competition drug test this past May. Mendes, who most recently lost to Frankie Edgar at the TUF 22 finale in December 2015, will not be eligible to compete again until June 10, 2018. As the disciplinary process is now complete, the USADA has confirmed that the substance Mendes tested positive for is GHRP-6.

GHRP-6 is otherwise known as growth hormone-releasing hexapeptide, and has the ability to release growth hormones in the body. These in turn can lead to differences in metabolism, muscle growth, and cardiac function, among other benefits.

This represents a huge blow for the UFC featherweight division, not to mention Team Alpha Male, where Mendes has consistently been one of the top fighters. Mendes twice challenged former featherweight champion Jose Aldo for his 145lb title, and also fought Conor McGregor for the interim featherweight title in 2015. He lost in all three title attempts, but remained the fourth ranked featherweight in the company.

About The Author

Senior Staff Writer

Covering the sport of MMA from Ontario, Canada, Jay Anderson has been writing for various publications covering sports, technology, and pop culture since 2001. Jay holds an Honours Bachelor of Arts degree in English from the University of Guelph, and a Certificate in Leadership Skills from Humber College under the Ontario Management Development Program. When not slaving at the keyboard, he can be found in the company of his dog, a good book, or getting lost in the woods.